ADAMII CD3/CD4/CD8 kit is intended for in vitro diagnostic use on ADAMII image based fluorescence cell counter. It identifies the absolute counts of human T lymphocytes(CD3+), helper/inducer(CD3+CD4+) T lymphocytes, and suppressor/cytotoxic(CD3+CD8+) T lymphocytes in RBC-lysed whole blood cell.
ADAMII CD3/CD4/CD8 counting is used to monitor the immune status of human immunodeficiency and autoimmune diseases. ADAMII CD3/CD4/CD8 targets of T cell responses to SARS-CoV-2 in human, so it can be used for vaccine development and monitoring for COVID-19 patients. As vaccine aim to elicit immune responses through CD4 T cells, understanding the dynamics of T-cell is essential in the vaccine development.